OKUR
OKUR
NASDAQ · Biotechnology

Onkure Therapeutics Inc-A

$3.79
-0.20 (-5.01%)
As of Mar 30, 10:12 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +454.1% upside
Low Target $13.91
Average Target $21.00
High Target $28.26
Current Price $3.79
Current
$3.79
Target
$21.00
$13.91 $21.00 avg $28.26
Scenario Analysis
Bear Case
$13.91
267.0%
Low target
Base Case
$21.00
+454.1%
Avg target
Bull Case
$28.26
+645.6%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$4.90
-22.7% from high
52-Week Low
$1.70
+122.9% from low
Target vs 52W High
$21.00
+328.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%